发明公开
EP2986604A1 PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
有权
PYRIMIDINSUBSTITUIERTE吡咯烷，其组合物及其用途制药
- 专利标题： PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
- 专利标题（中）： PYRIMIDINSUBSTITUIERTE吡咯烷，其组合物及其用途制药
-
申请号： EP14716333.1申请日： 2014-04-10
-
公开(公告)号： EP2986604A1公开(公告)日： 2016-02-24
- 发明人: FLECK, Martin , HEIMANN, Annekatrin , HEINE, Niklas , NOSSE, Bernd , ROTH, Gerald Juergen
- 申请人： Boehringer Ingelheim International GmbH
- 申请人地址： Binger Strasse 173 55216 Ingelheim am Rhein DE
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： Binger Strasse 173 55216 Ingelheim am Rhein DE
- 代理机构： Simon, Elke Anna Maria
- 优先权： EP13164172 20130417
- 国际公布： WO2014170197 20141023
- 主分类号： C07D405/14
- IPC分类号： C07D405/14 ; C07D413/14 ; C07D491/08 ; C07D403/04 ; C07D403/14 ; C07D417/14 ; C07D491/04 ; C07D498/04 ; A61P3/00 ; A61K31/506 ; A61K31/5377 ; A61K31/5386
摘要：
The invention relates to new pyrrolidine derivatives of the formula (I), wherein R
1 to R
3 , Ar, L T and n are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
1 to R
3 , Ar, L T and n are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
公开/授权文献
信息查询
